If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it?
Publication
, Journal Article
Cutter, GR; Sanders, DB
Published in: Neurotherapeutics
October 2021
In this issue of Neurotherapeutics, Li et.al. report a large retrospective study of the beneficial effects of thymectomy on the progression of ocular myasthenia gravis (OMG) to generalized MG (GMG) (Huanhuan et al. in Neurotherapeutics XX, 2021). This paper demonstrates a more than 50% reduction in the risk of GMG when a thymectomy was performed on these patients. The authors conclude with the recommendation that well-designed clinical trials be performed to evaluate the potential that thymectomy in OMG reduces the burden of GMG.
Duke Scholars
Published In
Neurotherapeutics
DOI
EISSN
1878-7479
Publication Date
October 2021
Volume
18
Issue
4
Start / End Page
2419 / 2420
Location
United States
Related Subject Headings
- Thymectomy
- Retrospective Studies
- Neurology & Neurosurgery
- Myasthenia Gravis
- Humans
- 5202 Biological psychology
- 3214 Pharmacology and pharmaceutical sciences
- 3209 Neurosciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Cutter, G. R., & Sanders, D. B. (2021). If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it? Neurotherapeutics, 18(4), 2419–2420. https://doi.org/10.1007/s13311-021-01139-x
Cutter, Gary R., and Donald B. Sanders. “If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it?” Neurotherapeutics 18, no. 4 (October 2021): 2419–20. https://doi.org/10.1007/s13311-021-01139-x.
Cutter GR, Sanders DB. If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it? Neurotherapeutics. 2021 Oct;18(4):2419–20.
Cutter, Gary R., and Donald B. Sanders. “If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it?” Neurotherapeutics, vol. 18, no. 4, Oct. 2021, pp. 2419–20. Pubmed, doi:10.1007/s13311-021-01139-x.
Cutter GR, Sanders DB. If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it? Neurotherapeutics. 2021 Oct;18(4):2419–2420.
Published In
Neurotherapeutics
DOI
EISSN
1878-7479
Publication Date
October 2021
Volume
18
Issue
4
Start / End Page
2419 / 2420
Location
United States
Related Subject Headings
- Thymectomy
- Retrospective Studies
- Neurology & Neurosurgery
- Myasthenia Gravis
- Humans
- 5202 Biological psychology
- 3214 Pharmacology and pharmaceutical sciences
- 3209 Neurosciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences